SCHEMBL21413719

SCHEMBL21413719

COc1cccc(C(=O)NC2CCC(O)C2)c1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 2/20 0.67
▸ ALDH1A1 P00352 2/20 0.59
▸ TSHR P16473 1/20 0.59
▸ NPC1 O15118 3/20 0.58
▸ MAPK1 P28482 1/20 0.55
▸ RAB9A P51151 3/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ LMNA P02545 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ MCHR1 Q99705 3/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ FAAH O00519 1/20 0.53
▸ CNR2 P34972 1/20 0.53
▸ PKM P14618 1/20 0.52
▸ HPGD P15428 1/20 0.52
▸ HPGDS O60760 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2468483 0.89 NPC1 (0.71) GRM5ALDH1A1TSHRNPC1MAPK1
SCHEMBL1667825 0.83 RAB9A (0.73) GRM5ALDH1A1TSHRNPC1MAPK1
SCHEMBL6455623 0.83 SMYD3 (0.69) GRM5ALDH1A1TSHRNPC1RAB9A
SCHEMBL6455626 0.83 SMYD3 (0.69) GRM5ALDH1A1TSHRNPC1RAB9A
SCHEMBL30184529 0.83 GRM5 (0.61) GRM5ALDH1A1TSHRNPC1MAPK1
SCHEMBL11241115 0.82 RAB9A (0.75) GRM5ALDH1A1TSHRNPC1MAPK1
SCHEMBL3663354 0.81 ALDH1A1 (0.61) GRM5ALDH1A1TSHRNPC1MAPK1
SCHEMBL1711687 0.80 ALDH1A1 (0.63) GRM5ALDH1A1TSHRNPC1MAPK1
SCHEMBL29530916 0.80 ALDH1A1 (0.63) GRM5ALDH1A1TSHRNPC1MAPK1
SCHEMBL30098987 0.80 ALDH1A1 (0.63) GRM5ALDH1A1TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10428080-B2 TBK/IKK inhibitor compounds and uses thereof MERCK PATENT GMBH (DE) 2019-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428080-B2 TBK/IKK inhibitor compounds and uses thereof NFKBIA, TBKBP1, TBK1 GRM5 3854/4885ALDH1A1 4646/4885TSHR 3067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback